...
首页> 外文期刊>Vaccine >Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in mice.
【24h】

Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in mice.

机译:小鼠对呼吸道合胞病毒附着蛋白的中央非糖基化区域的抗体反应。

获取原文
获取原文并翻译 | 示例
           

摘要

We examined the humoral immune response to the unglycosylated central region of the respiratory syncytial virus (RSV) attachment (G) protein in mice following intranasal challenge at day 0 (primary) and day 21 (secondary) with subtype A (A2 strain) or B (B1 strain) RSV preparations. Our serological screening reagents included bacterially derived glutathione S-transferase (GST) fusion proteins, each bearing a portion of the RSV G central core (CC; residues 151-190), proximal central core (PCC; residues 151-172), and the distal central core (DCC; residues 173-190) and purified RSV G proteins from subtype A and B viruses. Convalescent sera collected on day 21 following primary RSV infection bore robust IgG response primarily against the homosubtypic RSV G DCC with relatively modest antigen affinity/avidity as demonstrated by brief incubation with 6 M urea. In contrast, sera collected on day 42 following secondary homosubtypic RSV infection bore IgG titers of higher magnitudes and antigen affinity/avidity against the homosubtypic RSV G CC, PCC, and/or the DCC regions and full-length RSV G protein but not against the heterosubtypic RSV G protein or recombinant CC subdomains. In contrast, heterosubtypic secondary RSV infection elicits a broad array of IgG responses with titers of varying magnitudes to homo- and heterosubtypic RSV G CC regions as well as to purified F, Ga, and Gb proteins with the notable exception of minimal response to the RSV G DCC domain associated with the secondary RSV challenge. Our results have implications for RSV G-based serological assays as well as prophylactic immunotherapy and RSV vaccine development.CAS Registry Numbers 50812-37-8 308067-58-5
机译:我们在第0天(主要)和第21天(次要)使用亚型A(A2株)或B鼻内攻击后,检查了小鼠对呼吸道合胞病毒(RSV)附件(G)蛋白未糖基化中央区域的体液免疫反应(B1株)RSV制剂。我们的血清学筛选试剂包括细菌衍生的谷胱甘肽S-转移酶(GST)融合蛋白,每个蛋白带有一部分RSV G中央核心(CC;残基151-190),近端中央核心(PCC;残基151-172)和远端中央核心(DCC;残基173-190)和来自A和B型亚型病毒的纯化RSV G蛋白。原发性RSV感染后第21天收集的恢复期血清主要针对同型RSV G DCC具有较强的IgG反应,具有相对适度的抗原亲和力/亲和力,如与6 M尿素短暂孵育所证明。相反,继发同型亚型RSV感染后第42天收集的血清具有较高的IgG滴度,并且对同型RSV G CC,PCC和/或DCC区和全长RSV G蛋白具有较高的抗原亲和力/亲和力,但对异亚型RSV G蛋白或重组CC子域。相比之下,异型亚型继发RSV感染引起的IgG应答范围广泛,对同型和异型亚型RSV G CC区域以及纯化的F,Ga和Gb蛋白的滴度大小不同,但对RSV的响应极少。与次要RSV挑战相关的G DCC域。我们的研究结果对基于RSV G的血清学检测以及预防性免疫疗法和RSV疫苗的开发具有重要意义.CAS注册号50812-37-8 308067-58-5

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号